NASDAQ
SWAV

Shockwave Medical Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Shockwave Medical Inc Stock Price

Vitals

Today's Low:
$211.5
Today's High:
$223.66
Open Price:
$222.79
52W Low:
$172.5
52W High:
$320.54
Prev. Close:
$225.83
Volume:
1355775

Company Statistics

Market Cap.:
$8.17 billion
Book Value:
16.796
Revenue TTM:
$616.59 million
Operating Margin TTM:
24.55%
Gross Profit TTM:
$424.74 million
Profit Margin:
39.56%
Return on Assets TTM:
15.72%
Return on Equity TTM:
52.91%

Company Profile

Shockwave Medical Inc had its IPO on 2019-03-07 under the ticker symbol SWAV.

The company operates in the Healthcare sector and Medical Devices industry. Shockwave Medical Inc has a staff strength of 1,001 employees.

Stock update

Shares of Shockwave Medical Inc opened at $222.79 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $211.5 - $223.66, and closed at $213.

This is a -5.68% slip from the previous day's closing price.

A total volume of 1,355,775 shares were traded at the close of the day’s session.

In the last one week, shares of Shockwave Medical Inc have slipped by -4.23%.

Shockwave Medical Inc's Key Ratios

Shockwave Medical Inc has a market cap of $8.17 billion, indicating a price to book ratio of 22.3954 and a price to sales ratio of 17.2956.

In the last 12-months Shockwave Medical Inc’s revenue was $616.59 million with a gross profit of $424.74 million and an EBITDA of $158.44 million. The EBITDA ratio measures Shockwave Medical Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Shockwave Medical Inc’s operating margin was 24.55% while its return on assets stood at 15.72% with a return of equity of 52.91%.

In Q2, Shockwave Medical Inc’s quarterly earnings growth was a positive 11.8% while revenue growth was a positive 49.2%.

Shockwave Medical Inc’s PE and PEG Ratio

Forward PE
61.7284
Trailing PE
34.3756
PEG

Its diluted EPS in the last 12-months stands at $6.47 per share while it has a forward price to earnings multiple of 61.7284 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shockwave Medical Inc’s profitability.

Shockwave Medical Inc stock is trading at a EV to sales ratio of 18.0864 and a EV to EBITDA ratio of 80.4807. Its price to sales ratio in the trailing 12-months stood at 17.2956.

Shockwave Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$786.60 million
Total Liabilities
$80.22 million
Operating Cash Flow
$-83768000.00
Capital Expenditure
$8.75 million
Dividend Payout Ratio
0%

Shockwave Medical Inc ended 2024 with $786.60 million in total assets and $0 in total liabilities. Its intangible assets were valued at $786.60 million while shareholder equity stood at $616.91 million.

Shockwave Medical Inc ended 2024 with $10.42 million in deferred long-term liabilities, $80.22 million in other current liabilities, 37000.00 in common stock, $31.17 million in retained earnings and $39.79 million in goodwill. Its cash balance stood at $141.46 million and cash and short-term investments were $258.59 million. The company’s total short-term debt was $1,582,000 while long-term debt stood at $24.27 million.

Shockwave Medical Inc’s total current assets stands at $456.36 million while long-term investments were $2.54 million and short-term investments were $117.13 million. Its net receivables were $96.56 million compared to accounts payable of $12.87 million and inventory worth $92.09 million.

In 2024, Shockwave Medical Inc's operating cash flow was $-83768000.00 while its capital expenditure stood at $8.75 million.

Comparatively, Shockwave Medical Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$213
52-Week High
$320.54
52-Week Low
$172.5
Analyst Target Price
$294.78

Shockwave Medical Inc stock is currently trading at $213 per share. It touched a 52-week high of $320.54 and a 52-week low of $320.54. Analysts tracking the stock have a 12-month average target price of $294.78.

Its 50-day moving average was $244.78 and 200-day moving average was $237.4 The short ratio stood at 1.94 indicating a short percent outstanding of 0%.

Around 117.5% of the company’s stock are held by insiders while 9328.7% are held by institutions.

Frequently Asked Questions About Shockwave Medical Inc

The stock symbol (also called stock or share ticker) of Shockwave Medical Inc is SWAV

The IPO of Shockwave Medical Inc took place on 2019-03-07

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$2.04
0.09
+4.62%
$181.88
0.84
+0.46%
$684.45
-16.95
-2.42%
$430
-3.95
-0.91%
$122.6
1.8
+1.49%
$12.92
0.27
+2.13%
$91.99
-1.43
-1.53%
Praveg Ltd (PRAVEG)
$489.5
-9.9
-1.98%
$146.75
-2.05
-1.38%
$1.42
-0.31
-17.92%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Address

5403 Betsy Ross Drive, Santa Clara, CA, United States, 95054